Fotheringham Julie, Akhyani Nahid, Vortmeyer Alexander, Donati Donatella, Williams Elizabeth, Oh Unsong, Bishop Michael, Barrett John, Gea-Banacloche Juan, Jacobson Steven
Viral Immunology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
J Infect Dis. 2007 Feb 1;195(3):450-4. doi: 10.1086/510757. Epub 2006 Dec 27.
One-half of bone-marrow transplant (BMT) and stem-cell transplant recipients have reactivation of latent human herpesvirus (HHV)-6 2-4 weeks after transplant. Although the detection of viral DNA, RNA, and antigen in brain material confirmed active HHV-6 variant B infection, peak viral loads in cerebrospinal fluid (CSF) and serum occurred 2-4 weeks before death and decreased to low levels before or at autopsy. All autopsy samples consistently demonstrated HHV-6 active infection in the hippocampus. Astrocytic cells positive for viral antigen provided support for an HHV-6-specific tropism for hippocampal astrocytes. HHV-6 DNA in CSF and serum may not reflect the level of active viral infection in the brain after BMT.
骨髓移植(BMT)和干细胞移植受者中有一半在移植后2 - 4周出现潜伏性人类疱疹病毒(HHV)-6再激活。尽管在脑材料中检测到病毒DNA、RNA和抗原证实了HHV-6 B型变体的活跃感染,但脑脊液(CSF)和血清中的病毒载量峰值在死亡前2 - 4周出现,并在尸检前或尸检时降至低水平。所有尸检样本均在海马体中持续显示HHV-6活跃感染。病毒抗原呈阳性的星形细胞为HHV-6对海马体星形细胞的特异性嗜性提供了支持。脑脊液和血清中的HHV-6 DNA可能无法反映骨髓移植后脑内活跃病毒感染的水平。